Edition:
United Kingdom

BB Biotech AG (BION.S)

BION.S on Swiss Exchange

64.00CHF
16 Sep 2019
Change (% chg)

CHF0.15 (+0.23%)
Prev Close
CHF63.85
Open
CHF63.80
Day's High
CHF64.35
Day's Low
CHF63.60
Volume
55,728
Avg. Vol
70,642
52-wk High
CHF74.60
52-wk Low
CHF55.05

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2019 Jun '19 0.47 -6.060
Mar '19 578.87 16.059
FY 2018 Dec '18 -203.49 -11.557
Sep '18 253.87 4.370
Jun '18 1.19 -1.780
Mar '18 2.59 0.510
FY 2017 Dec '17 -143.78 -2.806
Sep '17 375.00 6.590
Jun '17 113.78 1.870
Mar '17 385.72 6.770
 
*Note: Units in Millions ofSwiss Francs
**Note: Units in Swiss Francs

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Year Ending Dec-19 3 151.05 453.15 0.00 0.00
Year Ending Dec-20 3 1.46 4.37 0.00 0.00
Earnings (per share)
Year Ending Dec-19 3 8.35 13.31 5.60 8.45
Year Ending Dec-20 2 4.90 5.53 4.27 9.03
Sales and Profit Figures in Swiss Franc (CHF);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) 4.38 69.39 32.66
P/E High - Last 5 Yrs. 5.00 147.53 47.31
P/E Low - Last 5 Yrs. 1.72 47.83 23.88
Beta 1.16 1.08 0.89
Price to Sales (TTM) 4.14 49.44 7.91
Price to Book (MRQ) 1.12 10.14 5.38
Price to Tangible Book (MRQ) 1.12 13.75 6.71
Price to Cash Flow (TTM) -- 55.95 24.36
% Owned Institutions -- 3.66 1.45

Dividends

  Company industry sector
Dividend Yield 4.08 0.12 1.35
Dividend Yield - 5 Year Avg 4.97 0.09 1.38
Dividend 5 Year Growth Rate -- 0.78 4.54
Payout Ratio(TTM) 18.00 7.01 40.24

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 128.80 205.58 12.23
Sales (TTM) vs TTM 1 Yr. Ago 581.84 49.07 7.74
Sales - 5 Yr. Growth Rate -- 22.80 10.88
EPS (MRQ) vs Qtr. 1 Yr. Ago 289.29 76.36 42.97
EPS (TTM) vs TTM 1 Yr. Ago 168.52 -- --
EPS - 5 Yr. Growth Rate -- 11.92 10.31
Capital Spending - 5 Yr. Growth Rate -- 9.20 14.84

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.23 2.21
Current Ratio (MRQ) 111.52 3.59 3.03
LT Debt to Equity (MRQ) 0.00 18.57 10.20
Total Debt to Equity (MRQ) 0.00 31.19 14.55
Interest Coverage (TTM) 0.07 -44.62 29.80

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 99.89 56.09 52.24
Gross Margin - 5 Yr. Avg. 99.85 60.28 50.41
EBITD Margin (TTM) 95.68 -- --
EBITD - 5 Yr. Avg 95.71 -110.43 13.12
Operating Margin (TTM) 93.94 -183.67 6.81
Operating Margin - 5 Yr. Avg. 73.89 -126.86 8.92
Pre-Tax Margin (TTM) 93.86 -174.38 5.99
Pre-Tax Margin - 5 Yr. Avg. 73.84 -132.62 9.22
Net Profit Margin (TTM) 93.86 -181.07 2.63
Net Profit Margin - 5 Yr. Avg. 73.82 -137.00 5.58
Effective Tax Rate (TTM) 0.01 22.42 22.40
Effective Tax Rate - 5 Yr. Avg. 0.03 15.43 22.75

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 7,668,830 887,293,452
Net Income/Employee (TTM) -- 533,008 101,845,288
Receivable Turnover (TTM) 78.54 6.23 5.93
Inventory Turnover (TTM) -- 1.88 3.36
Asset Turnover (TTM) 0.28 0.32 0.94

Management Effectiveness

  Company industry sector
Return on Assets (TTM) 26.71 6.40 11.17
Return on Assets - 5 Yr. Avg. 19.48 5.50 12.34
Return on Investment (TTM) 28.44 8.95 14.48
Return on Investment - 5 Yr. Avg. 20.43 6.82 16.02
Return on Equity (TTM) 28.44 10.09 15.78
Return on Equity - 5 Yr. Avg. 20.43 8.46 17.01
  1 Year 3 Year 5 Year
Sales % -98.64 -78.47 --
EPS (TTM) % -224.20 -- --
Dividend % -5.17 25.24 --
Note: Units in Millions of US Dollars

Performance for BB Biotech AG

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 7.85 3.88 99 98
13 Week 15.03 10.44 99 95
26 Week 19.63 11.72 99 97
52 Week 32.19 16.73 99 71
YTD 22.23 8.59 99 72
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 11.69%
# of Holders: 113
Total Shares Held: 6,474,955
3 Mo. Net Change: -281,590
# New Positions: 4
# Closed Positions: 7
# Increased Positions: 20
# Reduced Positions: 26
# Net Buyers: -6
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.